Home Newsfeeds BTIG Downgrades T2 Biosystems to Neutral

BTIG Downgrades T2 Biosystems to Neutral

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Binance CEO Says No ‘Master Plan’ To Take Over FTX, Warns Employees ‘DO NOT Trade FTT Tokens’

By Murtuza Merchant

November 9, 5:03 PM

Binance CEO Changpeng Zhao on Wednesday asserted he did not “master plan” the deal with FTX and the failure of Sam Bankman-Fried's cryptocurrency exchange was in no way a win for the world’s

$BNB

Analyst Ratings

Where Zentalis Pharma Stands With Analysts

By Benzinga Insights

August 10, 11:00 AM

Within the last quarter, Zentalis Pharma (NASDAQ:ZNTL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

ZNTL

Jefferies Reiterates Buy on Global Ship Lease, Maintains $25 Price Target

By Benzinga Newsdesk

March 1, 1:07 PM

Jefferies analyst Omar Nokta reiterates Global Ship Lease (NYSE:GSL) with a Buy and maintains $25 price target.

GSL

Nasdaq Jumps Over 100 Points; US Jobless Claims Edge Higher

By Avi Kapoor

December 7, 10:49 AM

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.04% to 36,068.53 while the NASDAQ rose 0.86% to 14,268.90. The S&P 500 also rose, gaining, 0.51% to 4,572.56.

BETS

BTIG Downgrades T2 Biosystems to Neutral

Related Posts

Binance CEO Says No ‘Master Plan’ To Take Over FTX, Warns Employees ‘DO NOT Trade FTT Tokens’

Where Zentalis Pharma Stands With Analysts

Jefferies Reiterates Buy on Global Ship Lease, Maintains $25 Price Target

Nasdaq Jumps Over 100 Points; US Jobless Claims Edge Higher